Index DJIA, S&P 500 P/E 17.51 EPS (ttm) 9.35 Insider Own 0.14% Shs Outstand 2.41B Perf Week 4.33%
Market Cap 393.87B Forward P/E 14.39 EPS next Y 11.37 Insider Trans -1.16% Shs Float 2.40B Perf Month 7.43%
Enterprise Value 407.35B PEG 2.62 EPS next Q 2.74 Inst Own 73.60% Short Float 0.66% Perf Quarter 6.36%
Income 22.66B P/S 4.35 EPS this Y 8.57% Inst Trans 1.15% Short Ratio 1.94 Perf Half Y 12.92%
Sales 90.63B P/B 5.04 EPS next Y 4.98% ROA 11.93% Short Interest 15.82M Perf YTD 13.19%
Book/sh 32.47 P/C 10.16 EPS next 5Y 6.68% ROE 29.45% 52W High 169.99 -3.70% Perf Year 8.40%
Cash/sh 16.12 P/FCF 19.34 EPS past 3/5Y -9.49% 0.55%ROIC 19.46% 52W Low 140.68 16.36% Perf 3Y -6.69%
Dividend Est. 5.05 (3.09%) EV/EBITDA 14.25 Sales past 3/5Y -1.79% 1.58%Gross Margin 75.44% Volatility 1.86% 1.51% Perf 5Y 12.73%
Dividend TTM 5.02 (3.07%) EV/Sales 4.49 EPS Y/Y TTM 29.21% Oper. Margin 23.88% ATR (14) 2.79 Perf 10Y 64.47%
Dividend Ex-Date Aug 26, 2025 Quick Ratio 1.03 Sales Y/Y TTM 4.69% Profit Margin 25.00% RSI (14) 67.68 Recom 2.24
Dividend Gr. 3/5Y 5.43% 5.54% Current Ratio 1.26 EPS Q/Q 18.30% SMA20 5.08% Beta 0.40 Target Price 176.79
Payout 84.80% Debt/Eq 0.67 Sales Q/Q 5.77% SMA50 5.99% Rel Volume 1.19 Prev Close 162.98
Employees 138100 LT Debt/Eq 0.49 Earnings Jul 16 BMO SMA200 5.44% Avg Volume 8.15M Price 163.70
IPO Sep 25, 1944 Option/Short Yes / Yes EPS/Sales Surpr. 3.29% 3.89% Trades
Volume 9,704,148 Change 0.44%
Date
Action
Analyst
Rating Change
Price Target Change
May-13-25 Downgrade Leerink Partners
Outperform → Market Perform
$153
Dec-10-24 Resumed BofA Securities
Neutral
$166
Nov-15-24 Initiated Wolfe Research
Outperform
$190
Jul-23-24 Downgrade Daiwa Securities
Outperform → Neutral
$160 → $150
May-30-24 Resumed Goldman
Neutral
$160
Apr-18-24 Upgrade HSBC Securities
Hold → Buy
$170
Dec-13-23 Downgrade Wells Fargo
Overweight → Equal Weight
$170 → $163
Dec-01-23 Upgrade UBS
Neutral → Buy
$167 → $180
Oct-05-23 Initiated RBC Capital Mkts
Outperform
$178
Sep-06-23 Initiated HSBC Securities
Hold
$175
May-30-23 Resumed Citigroup
Buy
$185
Mar-29-23 Initiated UBS
Neutral
$164
Mar-01-23 Initiated Guggenheim
Neutral
$161
Nov-18-22 Initiated Credit Suisse
Neutral
$170
Oct-18-22 Initiated Barclays
Equal Weight
$175
Oct-14-22 Reiterated BofA Securities
Neutral
$185 → $178
Jun-22-22 Initiated Daiwa Securities
Outperform
May-23-22 Resumed SVB Leerink
Outperform
$200
Apr-06-22 Resumed Morgan Stanley
Equal-Weight
$173
Mar-16-22 Downgrade Bernstein
Outperform → Mkt Perform
$180 → $183
Show Previous Ratings
Today 04:24PM
11:07AM
08:15AM
06:38AM
05:21AM
04:41AM
Loading…
04:41AM
01:11AM
Jul-17-25 07:04PM
02:25PM
01:20PM
11:00AM
09:42AM
09:40AM
09:15AM
09:10AM
08:00AM
Loading…
08:00AM
07:33AM
06:05AM
04:37AM
03:02AM
Jul-16-25 08:27PM
(Morningstar Research) +6.19%
06:01PM
05:35PM
05:05PM
(The Wall Street Journal)
04:55PM
(The Wall Street Journal)
04:50PM
04:44PM
(Investor's Business Daily)
04:16PM
04:08PM
04:06PM
(Investor's Business Daily)
04:05PM
Loading…
04:05PM
03:25PM
03:20PM
03:09PM
(The Wall Street Journal)
02:55PM
02:38PM
02:18PM
02:17PM
(Investor's Business Daily)
12:58PM
12:57PM
(Investor's Business Daily)
12:45PM
12:31PM
12:04PM
11:40AM
11:27AM
11:20AM
11:03AM
10:53AM
10:41AM
10:20AM
09:53AM
(The Wall Street Journal)
09:53AM
(The Wall Street Journal)
09:30AM
09:27AM
09:19AM
(The Wall Street Journal)
08:47AM
(Investor's Business Daily)
08:41AM
08:41AM
08:22AM
08:18AM
08:01AM
(Investor's Business Daily)
07:45AM
07:43AM
07:26AM
07:15AM
07:12AM
06:35AM
06:29AM
06:28AM
06:27AM
(Associated Press Finance)
06:27AM
(The Wall Street Journal)
06:26AM
06:25AM
06:20AM
06:20AM
05:30AM
05:18AM
04:27AM
(The Wall Street Journal)
03:43AM
(The Wall Street Journal)
12:09AM
Jul-15-25 07:00PM
06:50PM
06:50PM
06:50PM
05:52PM
(The Wall Street Journal)
04:55PM
09:10AM
06:30AM
05:08AM
04:17AM
(The Wall Street Journal)
03:00AM
Jul-14-25 05:09PM
04:58PM
04:58PM
04:45PM
(The Wall Street Journal)
04:24PM
(Investor's Business Daily)
11:50AM
11:03AM
10:24AM
(Investor's Business Daily)
10:08AM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
REED JOHN C EVP, Innovative Medicine, R&D Jul 17 '25 Sale 163.55 19,137 3,129,830 10,658 Jul 18 04:12 PM REED JOHN C Officer Jul 17 '25 Proposed Sale 163.55 19,137 3,129,831 Jul 17 04:05 PM REED JOHN C EVP, Innovative Medicine, R&D May 01 '25 Option Exercise 0.00 25,255 0 40,797 May 05 05:10 PM Decker Robert J VP Corporate Controller Feb 25 '25 Option Exercise 101.87 6,999 712,988 28,000 Feb 26 06:42 PM Decker Robert J VP Corporate Controller Feb 25 '25 Sale 165.88 6,999 1,160,994 21,001 Feb 26 06:42 PM Decker Robert J Officer Feb 25 '25 Proposed Sale 165.88 6,999 1,161,010 Feb 25 03:05 PM Schmid Timothy EVP, WW Chair, MedTech Feb 14 '25 Option Exercise 0.00 2,806 0 17,904 Feb 18 09:46 PM Schmid Timothy EVP, WW Chair, MedTech Feb 15 '25 Option Exercise 0.00 1,029 0 15,501 Feb 18 09:33 PM Schmid Timothy EVP, WW Chair, MedTech Feb 14 '25 Option Exercise 0.00 1,765 0 15,111 Feb 18 09:33 PM Schmid Timothy EVP, WW Chair, MedTech Feb 13 '25 Option Exercise 0.00 499 0 13,539 Feb 18 09:33 PM Schmid Timothy EVP, WW Chair, MedTech Feb 18 '25 Sale 156.15 403 62,928 15,098 Feb 18 09:33 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 15 '25 Option Exercise 0.00 607 0 91,037 Feb 18 09:16 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 14 '25 Option Exercise 0.00 7,367 0 96,674 Feb 18 09:16 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 13 '25 Option Exercise 0.00 651 0 89,603 Feb 18 09:16 PM Wolk Joseph J Exec VP, CFO Feb 15 '25 Option Exercise 0.00 1,971 0 6,113 Feb 18 09:13 PM Wolk Joseph J Exec VP, CFO Feb 14 '25 Option Exercise 0.00 19,330 0 20,661 Feb 18 09:13 PM Wolk Joseph J Exec VP, CFO Feb 13 '25 Option Exercise 0.00 1,779 0 1,779 Feb 18 09:13 PM REED JOHN C EVP, Innovative Medicine, R&D Feb 15 '25 Option Exercise 0.00 1,350 0 15,927 Feb 18 09:11 PM Taubert Jennifer L EVP, WWC. Innovative Medicine Feb 15 '25 Option Exercise 0.00 1,594 0 171,110 Feb 18 09:08 PM Taubert Jennifer L EVP, WWC. Innovative Medicine Feb 14 '25 Option Exercise 0.00 19,518 0 185,924 Feb 18 09:08 PM Taubert Jennifer L EVP, WWC. Innovative Medicine Feb 13 '25 Option Exercise 0.00 1,302 0 167,221 Feb 18 09:08 PM Swanson James D. EVP, CIO Feb 15 '25 Option Exercise 0.00 492 0 16,762 Feb 18 09:06 PM Swanson James D. EVP, CIO Feb 14 '25 Option Exercise 0.00 5,079 0 19,739 Feb 18 09:06 PM Swanson James D. EVP, CIO Feb 13 '25 Option Exercise 0.00 447 0 15,019 Feb 18 09:06 PM Mulholland Kristen EVP, Chief HR Officer Feb 15 '25 Option Exercise 0.00 419 0 13,095 Feb 18 09:05 PM Mulholland Kristen EVP, Chief HR Officer Feb 14 '25 Option Exercise 0.00 2,608 0 14,576 Feb 18 09:05 PM Mulholland Kristen EVP, Chief HR Officer Feb 13 '25 Option Exercise 0.00 411 0 12,100 Feb 18 09:05 PM Forminard Elizabeth Executive VP, General Counsel Feb 15 '25 Option Exercise 0.00 961 0 10,321 Feb 18 09:03 PM Forminard Elizabeth Executive VP, General Counsel Feb 14 '25 Option Exercise 0.00 2,203 0 11,366 Feb 18 09:03 PM Forminard Elizabeth Executive VP, General Counsel Feb 13 '25 Option Exercise 0.00 651 0 8,991 Feb 18 09:03 PM Duato Joaquin CEO and Chairman of the Board Feb 15 '25 Option Exercise 0.00 3,682 0 397,525 Feb 18 09:02 PM Duato Joaquin CEO and Chairman of the Board Feb 14 '25 Option Exercise 0.00 24,335 0 415,205 Feb 18 09:02 PM Duato Joaquin CEO and Chairman of the Board Feb 13 '25 Option Exercise 0.00 3,470 0 392,498 Feb 18 09:02 PM Decker Robert J VP Corporate Controller Feb 15 '25 Option Exercise 0.00 339 0 20,116 Feb 18 09:01 PM Decker Robert J VP Corporate Controller Feb 14 '25 Option Exercise 0.00 2,201 0 21,373 Feb 18 09:01 PM Decker Robert J VP Corporate Controller Feb 13 '25 Option Exercise 0.00 312 0 19,285 Feb 18 09:01 PM Broadhurst Vanessa EVP, Global Corp Affairs Feb 15 '25 Option Exercise 0.00 492 0 21,839 Feb 18 08:58 PM Broadhurst Vanessa EVP, Global Corp Affairs Feb 14 '25 Option Exercise 0.00 4,740 0 24,591 Feb 18 08:58 PM Broadhurst Vanessa EVP, Global Corp Affairs Feb 13 '25 Option Exercise 0.00 408 0 20,242 Feb 18 08:58 PM Duato Joaquin CEO and Chairman of the Board Feb 07 '25 Option Exercise 100.06 126,369 12,644,482 489,671 Feb 11 07:43 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 07 '25 Option Exercise 100.06 32,762 3,278,166 115,028 Feb 11 07:42 PM Taubert Jennifer L EVP, WWC. Innovative Medicine Feb 07 '25 Option Exercise 100.06 58,504 5,853,910 213,355 Feb 11 07:41 PM Wolk Joseph J Exec VP, CFO Feb 07 '25 Option Exercise 100.06 13,015 1,302,281 13,015 Feb 11 07:40 PM Wolk Joseph J Exec VP, CFO Feb 07 '25 Sale 153.89 13,015 2,002,878 0 Feb 11 07:40 PM Wolk Joseph J Officer Feb 07 '25 Proposed Sale 153.89 13,015 2,002,924 Feb 07 01:27 PM WEINBERGER MARK A Director Dec 12 '24 Buy 147.22 1,000 147,220 1,000 Dec 12 05:27 PM Hait William Former Officer Dec 04 '24 Proposed Sale 149.90 25,742 3,858,598 Dec 04 01:25 PM Decker Robert J VP Corporate Controller Aug 30 '24 Option Exercise 100.06 5,635 563,838 24,608 Sep 03 04:48 PM Decker Robert J VP Corporate Controller Aug 30 '24 Sale 165.06 5,635 930,113 18,973 Sep 03 04:48 PM Decker Robert J Officer Aug 30 '24 Proposed Sale 165.06 5,635 930,113 Aug 30 03:51 PM
